BFC Planning’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
BFC Planning's RIGL Position: Q3 2026 in Review
BFC Planning reduced its Rigel Pharmaceuticals (RIGL) stake by 67% in Q3 2026, selling an estimated $86.8K and leaving 1,000 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.
BFC Planning first reported a position in RIGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $117K in Q2 2026. 130 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- BFC Planning held 1,000 shares of Rigel Pharmaceuticals worth $48.2K as of Q3 2026.
- BFC Planning sold 2,000 Rigel Pharmaceuticals shares in Q3 2026, an estimated $86.8K.
- Rigel Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1575 holding.
- BFC Planning first reported a position in Rigel Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- BFC Planning's Rigel Pharmaceuticals position peaked at $117K in Q2 2026.
- 130 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.